Senate panel reviews H.545 amendments that shift immunization guidance to state commissioner and expand pharmacy authority

The Senate Health and Welfare Committee spent significant time Friday reviewing proposed amendments to H.545, a bill that would change how Vermont defines and implements recommended immunization guidance.

Presenter summarized multiple instances of amendment that together would: 1) create a state-defined "recommended immunization" schedule the commissioner of health periodically issues; 2) adjust membership on the Vermont Immunization Advisory Council (removing executive officers of the Board of Nursing and Board of Pharmacy in favor of practicing clinicians); 3) add a list of authorities under which a pharmacy technician may administer vaccines while a trained pharmacist is present; and 4) include liability-immunity language for health care professionals who prescribe or administer immunizations in accordance with the commissioner's recommendations unless their conduct is grossly negligent or intentional (SEG 720–755; SEG 781–806; SEG 952–965).

The presenter noted timing and sunset mechanics: sections 1–7 and 14 would take effect on passage, while sections 8–13 would take effect on 07/01/2031 and mostly revert to current, CDC-linked language at that later date; certain reworked pharmacy provisions would remain in force under the amendment structure (SEG 904–912; SEG 1032–1041). The presenter said deleting section 13 would make the rewritten pharmacy authorities the new status quo and avoid a reversion on the 2031 date for that piece (SEG 811–831).

Committee members raised a substantive concern: if Vermont’s recommended immunization list differs from a future federal list, would affected vaccines still be covered by the federal Vaccine Injury Compensation Program (VICP) and related federal purchase or funding arrangements? Lauren Laymon, general counsel for the Department of Health, said the state currently purchases Vaccines for Children through a state contract (the state pays the federal program and distributes vaccine to providers) and that, for now, vaccines remain covered by VICP and patients receive vaccines at no cost. She cautioned that VICP processes for petitions can be lengthy and that the department would hesitate to preemptively flag state materials unless and until federal coverage changes (SEG 1156–1163; SEG 1271–1296). "Right now, all the vaccines are still covered, by VICP," Laymon said. "If the vaccine is on our list but not on the federal list... then I would have to hire a lawyer to go to court and sue the vaccine manufacturer," a committee member observed in describing the practical difference (SEG 1369–1378).

Stakeholder input included testimony from Stephanie Winters (Vermont Medical Society and pediatric and family-physician organizations), who noted that Vaccine Information Statements (VIS) already mention the National Vaccine Injury Compensation Program and are regularly provided to patients (SEG 1335–1344).

Committee leadership asked members to digest the amendment language over the weekend; the committee plans to return Tuesday for final markup and a potential vote. A staff presenter said she would prepare the amendments as a strike-all to give senators a clearer, single document for floor consideration if the committee favors that approach (SEG 1369–1406; SEG 836–886).